IP Library › Assignment 031950/0443
Patent Assignment
Reel/Frame 031950/0443

Conditional Assignment

Recorded: 2014-01-13 Pages: 7
Assignor
ALLTRANZ, INC.
Executed: 2012-12-13
Assignee
KENTUCKY ECONOMIC DEVELOPMENT FINANCE AUTHORITY
300 WEST BROADWAY, OLD CAPITOL ANNEX, FRANKFORT, KENTUCKY, 40601
Covered Properties (41)
Transdermal Delivery of Cannabinoids
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Methods and Compositons for Enhancing the Viability of Microneedle Pores
Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Cannabinoid-Containing Compositions and Methods for Their Use
Formulations of Cannabidiol and Prodrugs of Cannabidiol and Methods of Using the Same
Use of Cannabidiol Prodrugs in Topical and Transdermal Administration with Microneedles
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Transdermal delivery of cannabinoids
Application: 10/032,163 →
Publication: US 2002/0111377
Transdermal Delivery of Cannabidiol
Patent: 8,449,908 →
Application: 11/157,034 →
Publication: US 2005/0266061
Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis(hydroxy-methyl)propionyl-3-0 ester naltrexone using microneedles
Application: 11/812,249 →
Publication: US 2008/0008745
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Patent: 7,511,054 →
Application: 11/860,432 →
Publication: US 2008/0076789
Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion
Patent: 8,653,271 →
Application: 11/907,954 →
Publication: US 2009/0017102
Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Patent: 8,293,786 →
Application: 12/182,974 →
Publication: US 2009/0036523
Methods and Compositions for Enhancing the Viability Of Microneedle Pores
Application: 12/325,919 →
Publication: US 2009/0143762
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Patent: 8,227,627 →
Application: 12/326,036 →
Publication: US 2009/0143462
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Patent: 8,309,568 →
Application: 12/388,891 →
Publication: US 2009/0156814
Cannabinoid-Containing Compositions and Methods for Their Use
Application: 12/399,392 →
Publication: US 2009/0247619
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Application: 12/412,189 →
Publication: US 2009/0246265
Transdermal Delivery of Cannabidiol
Patent: 8,435,556 →
Application: 12/511,226 →
Publication: US 2009/0291128
Formulations of Cannabidiol and Prodrugs of Cannabidiol and Methods of Using the Same
Application: 12/769,519 →
Publication: US 2010/0273895
Use of Cannabidiol Prodrugs in Topical and Transdermal Administration with Microneedles
Application: 12/873,248 →
Publication: US 2011/0052694
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Patent: 8,481,560 →
Application: 13/079,758 →
Publication: US 2011/0245783
Transdermal Delivery of Cannabinoids
Application: 13/271,338 →
Publication: US 2012/0034293
Cannabinoid-Containing Compositions and Methods for Their Use
Application: 13/318,208 →
Publication: US 2012/0202891
Cannabinoid-Containing Compositions and Methods for Their Use
Application: 13/451,666 →
Publication: US 2012/0202892
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Patent: 8,980,942 →
Application: 13/555,741 →
Publication: US 2012/0289484
Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
Application: 13/670,865 →
Publication: US 2013/0123292
Transdermal delivery of cannabinoids
Application: 60/257,557 →
Transdermal Delivery of Opioid Agonists or Agonist-Antagonists with or Without Abuse-Deterrent Opioid Antagonist Particles
Application: 60/826,603 →
Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
Application: 60/952,746 →
Methods and Compositions for Enhancing the Viability of Microneedle Pores
Application: 60/990,972 →
Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Application: 60/991,555 →
Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
Application: 61/037,568 →
Abuse Deterrent Transdermal Formulations of Opiate Agonists and Agonist-Antagonists
Application: 61/039,763 →
Evaluation of cannabidiol in the complete Freund's adjuvant-induced mono-arthritis rat model
Application: 61/068,328 →
Formulations of Cannabidiol and Prodrugs of Cannabidiol and Methods of Using the Same
Application: 61/173,469 →
Use of Cannabidiol and Prodrugs of Cannabidiol in Topical and Transdermal Administration with Microneedles
Application: 61/238,524 →
Abuse Deterrent Transdermal Drug Delivery System for Opiate Agonists and Agonist-Antagonists
Application: 61/320,526 →
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 30, 2012
From: LYNN, AUDRA; BANKS, STAN LEE
To: ALLTRANZ INC.
Reel/Frame 028130/0063 →
Assignment of Assignor's Interest Jun 27, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE
To: ALLTRANZ INC.
Reel/Frame 028450/0497 →
Assignment of Assignor's Interest Jun 28, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE; GOLINSKI, MAROSLAW JERZY; HOWARD, JEFFREY LYNN
To: ALLTRANZ INC.
Reel/Frame 028460/0859 →
Corrective Assignment to Correct the the 1ST Name of the 3RD Inventor Miroslaw. Previously Recorded on Reel 028460 Frame 0859. Assignor(S) Hereby Confirms the Correct Spelling for the 3RD Inventor Is Miroslaw.. Jun 29, 2012
From: STINCHCOMB, AUDRA LYNN; BANKS, STAN LEE; GOLINSKI, MIROSLAW JERZY; HOWARD, JEFFREY LYNN
To: ALLTRANZ INC.
Reel/Frame 028488/0291 →
Assignment of Assignor's Interest Feb 1, 2013
From: STINCHCOMB, AUDRA LYNN; LI, GUOHUA; BANKS, STAN LEE; HOWARD, JEFFERY LYNN
To: ALLTRANZ INC.
Reel/Frame 029737/0094 →
Release of Security Interest Sep 25, 2014
From: KENTUCKY ECONOMIC DEVELOPMENT FINNCE AUTHORITY
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 033816/0866 →
Change of Name Oct 13, 2014
From: ALLTRANZ, INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 033937/0246 →
Change of Name Dec 11, 2014
From: ALLTRANZ INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 034477/0690 →
Assignment of Assignor's Interest Dec 22, 2014
From: ZYNERBA PHARMACEUTICALS, INC.
To: BUZZZ PHARMACEUTICALS LTD.
Reel/Frame 034571/0991 →
Change of Name Dec 22, 2014
From: ALLTRANZ INC.
To: ZYNERBA PHARMACEUTICALS, INC.
Reel/Frame 034571/0914 →
Assignment of Assignor's Interest Dec 23, 2014
From: ZYNERBA PHARMACEUTICALS, INC.
To: STINCHCOMB, AUDRA LYNN
Reel/Frame 034581/0065 →
Assignment of Assignor's Interest Jun 19, 2023
From: STINCHCOMB, AUDRA L.; NALLURI, BUCHI N.
To: ALLTRANZ, LLC
Reel/Frame 063986/0951 →
Supplemental Confirmatory Grant of Security Interest in United States Patents May 18, 2026
From: HARMONY BIOSCIENCES MANAGEMENT, INC. (F/K/A ZYNERBA PHARMACEUTICALS, INC.)
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075642/0639 →